A prospective multi-centre Phase III validation study of AZGP1 as a biomarker in localized prostate cancer

Activity: Talk or presentation › Presentation

Period13 Feb 2017 → 15 Feb 2017
Event titleLorne Cancer Conference
Event typeConference
LocationAustralia, VictoriaShow on map
Degree of RecognitionLocal